Aldeyra Therapeutics Inc (ALDX)

SG&A Expenses

$1.14T

TTM · Period ending: · USD

ALDX logo

ALDX SG&A Expenses

Latest reported$1.14T
ALDX TTM SG&A Expenses ($2.13M → $1.14T)
High-resolution chart · PNG

ALDX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aldeyra Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
1,137,350,300,705
1,137,349,598,215
9,602,350
9,185,765
10,311,457
11,686,018
11,892,240
11,743,984
10,636,618
10,978,304
13,335,363
16,271,186
16,927,421
16,691,951
15,373,922
13,201,446
12,503,317
12,427,689
11,283,004
11,225,154
10,933,964
10,085,315
9,985,454
10,694,392
11,278,094
12,174,505
12,154,702
11,486,771
11,713,364
10,970,009
9,876,274
8,831,520
7,241,512
6,350,245
6,185,820
5,890,399
5,811,229
5,791,664
5,520,345
5,541,053
5,405,515
4,898,167
4,414,709
4,195,530
3,706,801
3,734,501
3,563,046
3,388,057
3,116,006
2,794,067
2,134,726
1,322,615
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.